Trial Profile
Phase 1 study of reboxetine adjuvant therapy and cognitive and behavioral measures.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Reboxetine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 18 Dec 2006 New trial record.